Protalix Biotherapeutics Inc (NYSE American:PLX)
| 3.60 BATS BZX Real-Time Price As of 2:18pm ET |  +0.03 / +0.84%Today’s Change | 1.70 Today|||52-Week Range 4.87 | +9.76% Year-to-Date |
Latest PLX News | Press Releases
No recent news for Protalix Biotherapeutics Inc.
Today’s Trading
| Previous close | 3.57 |
| Today’s open | 3.56 |
| Day’s range | 3.55 - 3.60 |
| Volume | 46,609 |
| Average volume (3 months) | 203,050 |
| Market cap | $117.4M |
Data as of 2:18pm ET, 08/04/2020
Growth & Valuation
| Earnings growth (last year) | +31.50% |
| Earnings growth (this year) | +55.69% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +59.73% |
| P/E ratio | NM |
| Price/Sales | 0.89 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CBIOCatalyst Biosciences... | -0.06 | -1.13% |
| LJPCLa Jolla Pharmaceuti... | +0.18 | +4.44% |
| ELOXEloxx Pharmaceutical... | +0.12 | +3.93% |
| SLDBSolid Biosciences In... | -0.11 | -4.20% |
Data as of 2:33pm ET, 08/04/2020
Financials
| Next reporting date | August 6, 2020 |
| EPS forecast (this quarter) | -$0.21 |
| Annual revenue (last year) | $54.7M |
| Annual profit (last year) | -$18.3M |
| Net profit margin | -33.42% |
Profile
Sector Health Services |
Industry Services to the Health Industry |
No executives to display |
Corporate headquarters Karmiel, Hazafon |
Forecasts
